BUY-SIDE

Analyst

Visible Alpha Insights provides an innovative, integrated experience and instant access to full working sell-side models, granular consensus estimates and industry-level analysis to optimize your workflow, improve efficiency and boost your confidence in recommending investment ideas.

DIVE DEEPER

Hone in on the fundamental drivers of companies important to you

INCREASE EFFICIENCY

Instantly discover investment controversies and compare line items at an industry level

CUSTOMIZE YOUR EXPERIENCE

Integrate broker and consensus data directly into your own models

Optimize Your Workflow:

Normalized Data: Compare company line items across analysts and side-by-side with consensus
Standardized Data: Build comprehensive comp tables with industry-specific operating metrics
Pre- and Post-Earnings Analysis: Create custom automated earnings previews and leverage surprise and revisions analysis tools for past company performance
Real-Time Access: Receive model revisions in real time and access the latest consensus estimates
Integrated Sell-Side Content: Leverage our powerful research viewer to interact with model data while reading research reports
Excel Add-In: Export the Street’s most up-to-date forecasts directly into your models

Products We Offer:

Insights

* We also offer Consensus Only Insights

“Visible Alpha saves me hours each week by updating consensus metrics for companies in my coverage”

Analyst, $750M Long-Short Hedge Fund

“I have built in Visible Alpha ‘consensus’ sheets into all my models.”

Analyst, $1B Credit Hedge Fund

“You have interesting data that I can’t find anywhere else.”

Analyst, $8-12B Multi-Strategy Fund

“I used to spend 5 hours doing [research and analysis], now I spend 2 minutes”

Analyst, $1.5B Directional Hedge Fund

Excel Add-In for Insights

Leverage the power of Visible Alpha Insights directly in Excel
Incorporate the latest analyst and consensus forecasts directly into your own models. Easily identify bullish or bearish trends by seeing how estimates have changed over time, and see how revisions for key drivers have changed compared to your own estimates.

Learn More

“Your plug-in is a game-changer.”
— Analyst, $20-25B Activist Long/Short Hedge Fund

108,000+

Standardized Line Items
as of Aug 2021

125+

Contributing Brokers

6000+

Company Coverage

161

Average Consensus Line Items Per Company

81,812

Models Processed Last Quarter

Request A Demo

Services

We are here to empower you to achieve your goals

Increasing Coverage
We’re constantly increasing coverage across the globe, but if a broker or company you want is not on the platform, we’ll work with you to onboard them or initiate coverage.

Continuous Enhancements
With a SaaS model, you will always have the latest version of our product, as we work on an endless cycle to solicit and incorporate client feedback into new features and capabilities.

Effortless Onboarding
We will guide you through discovering the available features, functions and capabilities, and work with you to integrate the product to best enhance your current workflow.

Learn More

Download the “first of its kind” Jefferies biotech report

In this report, Jefferies Equity Research examined 180 U.S. biotech stocks using Visible Alpha’s proprietary consensus forecast data as a primary source of information. By leveraging our consensus estimates, the Jefferies Equity Research Biotech team was able to discern where their theses deviated from consensus on granular line items that are not available through traditional consensus providers. Download the report to see how you can use Visible Alpha’s consensus data for your investment research process.

Forecasting the Global Business Impact and Recovery from Covid-19
A Global Meta-Analysis of Investment Research Analyst Forecasts While the world reels from the social and economic shocks caused by the Covid-19 pandemic and the measures taken to mitigate its impact, the rebound in equity markets suggests that investors are already looking forward to a return to some semblance of…

COVID-19 Analyst Revisions Ahead of Earnings Season
Earnings season is here, and companies are expected to update full-year guidance to reflect the impact of the COVID-19 crisis. As events have unfolded since the start of the year some analysts have made revisions to their estimates accordingly. Historical consensus estimates from January 1, 2020 represent a pre-COVID view.…

Zillow Analysts Bullish On Core Business But Skeptical of iBuyer Model
Questionable Profits Zillow analysts have widely different views on the company’s future profitability as they transform into a real estate iBuyer. The company is in the midst of an ambitious multi-year transition to “Zillow 2.0” that began in 2018 with Zillow Offers, a program allowing homeowners to sell directly to…

Analyst

DIVE DEEPER

INCREASE EFFICIENCY

CUSTOMIZE YOUR EXPERIENCE

Optimize Your Workflow:

Products We Offer:

Excel Add-In for Insights

“Your plug-in is a game-changer.”
— Analyst, $20-25B Activist Long/Short Hedge Fund

Request A Demo

Services

Download the “first of its kind” Jefferies biotech report

Forecasting the Global Business Impact and Recovery from Covid-19

COVID-19 Analyst Revisions Ahead of Earnings Season

Zillow Analysts Bullish On Core Business But Skeptical of iBuyer Model

Request A Demo

Company

Products

Client Access

Call Us

Analyst

Optimize Your Workflow:

Products We Offer:

Excel Add-In for Insights

“Your plug-in is a game-changer.”— Analyst, $20-25B Activist Long/Short Hedge Fund

Request A Demo

Services

Download the “first of its kind” Jefferies biotech report

Request A Demo

Company

Products

Client Access

Call Us

“Your plug-in is a game-changer.”
— Analyst, $20-25B Activist Long/Short Hedge Fund